|
PMID
|
Match String
|
Actual String
|
Score
|
Flanking text
|
Edited by
|
Edit
|
| 16647138 | CB1 | CB1 | 0.6 | slices was facilitated following treatment with a cannabinoid receptor (CB1) CB1 antagonist revealing a tonic inhibitory influence of eCBs on LTP | |  |
| 16647138 | CB1 | CB1 | 0.6 | leading to the conclusion that COX-2 regulates the formation of CB1 ligands that negatively regulate LTP | |  |
| 17241118 | CB1 | CB1 | 0.9 | Cannabinoids produce anti-inflammatory actions via cannabinoid receptor 1 (CB1) CB1 and cannabinoid receptor 2 (CB2), CB2 and delay the progression | |  |
| 17241118 | CB1 | CB1 | 0.9 | that mRNA receptor binding and function of CB2 but not CB1 receptors are dramatically and selectively up-regulated in spinal cords of | |  |
| 16647138 | cannabinoid receptor 1 | cannabinoid receptor 1 | 1.0 | aea and maea increased the expression of cox 2 protein an action that am 251 a selective cannabinoid receptor 1 agonist partially inhibited. | |  |
| 16647138 | cannabinoid receptor 1 | cannabinoid receptor 1 | 1.0 | 2005 suggested that aea increases cox 2 expression at the transcriptional level through a cannabinoid receptor 1 mediated mechanism in the cerebral microvascular endothelium. | |  |
| 17241118 | cannabinoid receptor 1 | cannabinoid receptor 1 | 1.0 | cannabinoids produce anti inflammatory actions via cannabinoid receptor 1 cb1 and cannabinoid receptor 2 cb2 and delay the progression of neuroinflammatory diseases. | |  |